Literature DB >> 9063906

Comments and reply on Ikeguchi and Kuroda: Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.

J H Friedman, K Ikeguchi, A Kuroda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9063906     DOI： 10.1007/bf02274901

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  4 in total

1.  Mianserin, a 5-HT2 receptor antagonist, in the treatment of delirium: an open study.

Authors:  K Ikeguchi; A Kuroda
Journal:  Eur J Neurol       Date:  1995-01       Impact factor: 6.089

2.  Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist.

Authors:  J Zoldan; G Friedberg; M Livneh; E Melamed
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

3.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

4.  Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.

Authors:  K Ikeguchi; A Kuroda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.